Ömür Tabak
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
-
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
-
- Paraoxonase enzyme and polymorphisms 6
-
- Diabetes Management and Research 5
- Diet, Metabolism, and Disease 4
- Diabetes Treatment and Management 4
- Co-authors
- Hafize UzunFüsun ErdenenRemise GelışgenHayriye ErmanReşat ÖzarasHale AralFehmı TabakVolkan Sözer
- Journals
- Clinical and investigative medicine (3 papers)Scientific Reports (2 papers)Biomarkers in Medicine (2 papers)Diabetes Obesity and Metabolism (2 papers)Digestive Diseases and Sciences (2 papers)
- Partner nations
- TürkiyeUnited StatesDenmark
In The Last Decade
Ömür Tabak
40 papers receiving 633 citations
Peers
Comparison fields: 5 of 94
- Clinical Biochemistry 57
- Endocrinology, Diabetes and Metabolism 133
- Hepatology 57
- Epidemiology 170
- Physiology 109
Countries citing papers authored by Ömür Tabak
This map shows the geographic impact of Ömür Tabak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömür Tabak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömür Tabak more than expected).
Fields of papers citing papers by Ömür Tabak
This network shows the impact of papers produced by Ömür Tabak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömür Tabak. The network helps show where Ömür Tabak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ömür Tabak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 0 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 7 | |
| 10 | 2019 | 35 | |
| 11 | 2017 | 1 | |
| 12 | 2017 | 6 | |
| 13 | 2013 | 5 | |
| 14 | 2012 | 18 | |
| 15 | 2011 | 13 | |
| 16 | 2011 | 106 | |
| 17 | 2010 | 14 | |
| 18 | 2009 | 17 | |
| 19 | 2008 | 19 | |
| 20 | 2007 | 8 |
About Ömür Tabak
Ömür Tabak is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Hepatology, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 45 papers that have together received 646 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Paraoxonase enzyme and polymorphisms (6 papers), Diabetes Management and Research (5 papers), Cardiovascular Disease and Adiposity (4 papers), COVID-19 Clinical Research Studies (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Diet, Metabolism, and Disease (4 papers) and Diabetes Treatment and Management (4 papers). The work is most often cited by research in Clinical Biochemistry (57 citations), Endocrinology, Diabetes and Metabolism (133 citations), Hepatology (57 citations), Epidemiology (170 citations) and Physiology (109 citations). Ömür Tabak has collaborated with scholars based in Türkiye, United States and Denmark. Frequent co-authors include Hafize Uzun, Füsun Erdenen, Remise Gelışgen, Hayriye Erman, Reşat Özaras, Hale Aral, Fehmı Tabak, Volkan Sözer, Veysel Tahan and Gülcan Güntaş. Their work appears in journals such as Clinical and investigative medicine, Scientific Reports, Biomarkers in Medicine, Diabetes Obesity and Metabolism and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.